Carol Felder, DENTIST in Bridgeport, CT - Dentist

Carol Felder, DENTIST is a Dentist - General Practice based in Bridgeport, Connecticut. Carol Felder is licensed to practice in Connecticut (license number 008788) and her current practice location is 471 Barnum Ave, Bridgeport, Connecticut. She can be reached at her office (for appointments etc.) via phone at (203) 333-6864.

NPI number for Carol Felder is 1922097088 and her current mailing address is 471 Barnum Ave, Bridgeport, Connecticut. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1922097088.

Contact Information

	Carol Felder, DENTIST
	471 Barnum Ave, Bridgeport, CT 06608-2409
	(203) 333-6864
	(203) 332-0376

Healthcare Provider's Profile

Full Name	Carol Felder
Gender	Female
Speciality	Dentist - General Practice
Location	471 Barnum Ave, Bridgeport, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1922097088
Provider Enumeration Date: 10/20/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Carol Felder such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922097088	NPI	-	NPPES
008788	Other	CT	CT STATE :LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	008788 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carol Felder is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carol Felder, DENTIST 471 Barnum Ave, Bridgeport, CT 06608-2409 Ph: (203) 333-6864	Carol Felder, DENTIST 471 Barnum Ave, Bridgeport, CT 06608-2409 Ph: (203) 333-6864

News Archive

Secondhand smoke exposure during pregnancy causes permanent genetic damage in newborns

Newborns of non-smoking moms exposed to secondhand smoke during pregnancy have genetic mutations that may affect long-term health, according to a University of Pittsburgh Graduate School of Public Health study published online in the Open Pediatric Medicine Journal. The abnormalities, which were indistinguishable from those found in newborns of mothers who were active smokers, may affect survival, birth weight and lifelong susceptibility to diseases like cancer.

CDC takes critical step to reinvigorate fight against tobacco use

The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: The Centers for Disease Control and Prevention today has taken a critical step to reinvigorate the fight against tobacco use – the nation's leading preventable cause of death – by launching the government's first-ever paid, nationwide media campaign to encourage smokers to quit and prevent children from starting to smoke.

UGA researchers explore new ways of predicting thunderstorm asthma outbreaks

As allergy sufferers can attest, thunderstorm activity can exacerbate asthma and respiratory ailments. In fall 2016, when strong storms moved across southeastern Australia, a major thunderstorm asthma epidemic struck Melbourne and the surrounding area. High grass pollen concentrations dispersed by strong, gusty winds led to multiple deaths and a flood of residents seeking medical attention for respiratory problems.

GORE VIABIL Biliary Endoprosthesis receives European CE Mark approval for expanded indication

W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

Dentist in Bridgeport, CT

Giuliana Novoa-ordonez, DDS Dentist Medicare: Medicare Enrolled Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3270 Fax: 203-334-8104
Frank J Romano, DMD Dentist Medicare: Medicare Enrolled Practice Location: 2240 Madison Ave, Bridgeport, CT 06606 Phone: 203-327-0881
Dr. Francis Vincent Tiberi, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3015 Main St, Bridgeport, CT 06606 Phone: 203-365-0015 Fax: 203-365-0020
Dr. Michael Salpeter, DMD Dentist Medicare: Medicare Enrolled Practice Location: 633 Clinton Ave, Bridgeport Dental Llc, Bridgeport, CT 06605 Phone: 203-384-2261
Dr. Payal Jain, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2660 Main St, # 217, Bridgeport, CT 06606 Phone: 203-219-0285
Leonard Lipton, DDS Dentist Medicare: Medicare Enrolled Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3260 Fax: 203-332-0376
Weruche Chinyere Okonkwo, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 468 Clinton Ave, Bridgeport, CT 06605 Phone: 203-337-6266 Fax: 203-337-6261

Carol Felder, DENTIST - Dentist in Bridgeport, CT